JD Sports keen on expanding its business beyond national borders
Category: #retail  By Saipriya Iyer  Date: 2018-04-18
  • share
  • Twitter
  • Facebook
  • LinkedIn

JD Sports keen on expanding its business beyond national borders

In a move to expand its business across the Asia Pacific zone, JD Sports, Sports & Leisurewear retailer, has launched its stores in South Korea and Australia. Last year alone, the retail giant had established nine new retail stores in the APAC region.

For the record, the firm has nearly fifty-six retail stores across the European Zone. In March this year, the company decided to acquire Finish Line, Inc., a shoe retailer, for £400 million. Peter Cowgill, the executive chairman of JD Sports, has proclaimed that since the U.S. is a huge market, the acquisition will provide the firm an opportunity to increase its geographical presence.

In 2017, the sports fashion retail firm had accrued soaring profits, registering a 24% increase in the pre-tax profit to £294.5 million. Its turnover increased by 33%, rising to £3.2 billion till 3rd February of this year, a landmark achievement in the history of the organization. Experts view that JD Sport’s performance has proved to be an exception as compared to other retail organizations that have experienced a decline in their revenues owing to tough competition from online retail stores, escalating wages, and decrease in the football popularity.

One of the key officials of the firm has credited the company’s success to its most aspiring leisurewear and footwear products. It has been reported that JD even accrued a huge revenue via its outdoor business, which include Blacks, Go Outdoors, and Millets. The firm has earned EBITDA of nearly £23 million this year as compared to £7 million during the same period last year.

The executive chairman of the sports retail firm has stated that though brick and mortar are the focus of JD Sports, it is investing more in the eCommerce business activities with a goal of spanning a wider consumer base, making its presence felt across the globe.



About Author

Saipriya Iyer

Email: [email protected]   

Saipriya Iyer

Saipriya Iyer develops content for Market Size Forecasters, Algosonline, and myriad other platforms. A computer engineer by profession, she ventured into the field of writing for the love of playing with words. Having had a previous experience of 3 years under her bel...

Read More

More News By Saipriya Iyer

PharmaCyte to submit IND application to FDA for clinical trial in LAPC
PharmaCyte to submit IND application to FDA for clinical trial in LAPC
By Saipriya Iyer

PharmaCyte Biotech, a clinical-stage biotechnology company, is reportedly set to submit an IND (Investigational New Drug) application to the U.S. FDA. The IND application is related to the Phase 2b clinical trial among...

Immunic announces topline data from Phase 2 EMPhASIS, IMU-838 trial
Immunic announces topline data from Phase 2 EMPhASIS, IMU-838 trial
By Saipriya Iyer

Immunic, Inc. has recently announced positive topline results from the Phase 2 EMPhASIS trial of IMU-838, in patients with RRMS (relapsing-remitting multiple sclerosis). IMU-838 is a next-generation, orally available s...

Ciox announces acquisition of biomed-NLP technology company, Medal
Ciox announces acquisition of biomed-NLP technology company, Medal
By Saipriya Iyer

Ciox Health has recently announced the acquisition of Medal, Inc., a biomed-NLP (biomedical Natural Language Processing) technology company based in San Francisco. Medal is also a leader in integrating AI techniques fo...